IRIS
CANEPA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.858
Totale 8.858
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 8.858
Totale 8.858
Salva come PNG Salva come JPEG
Città #
Genova 6.227
Rapallo 1.034
Genoa 945
Vado Ligure 619
Bordighera 33
Totale 8.858
Salva come PNG Salva come JPEG
Nome #
Using unsupervised learning to determine risk level for left ventricular diastolic dysfunction2014 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 178
Neurohormonal activation and pharmacological inhibition in pulmonary arterial hypertension and related right ventricular failure 169
Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes 168
The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity 161
5-fluorouracil causes endothelial cell senescence: Potential protective role of glucagon-like peptide 1 153
Testosterone Antagonizes Doxorubicin-Induced Senescence of Cardiomyocytes 142
E / e' ratio and outcome prediction in hypertrophic cardiomyopathy: The influence of outflow tract obstruction 140
Distinguishing ventricular septal bulge versus hypertrophic cardiomyopathy in the elderly 139
Correlation between thoracic aorta 18F-natrium fluoride uptake and cardiovascular risk 139
T1 mapping with cardiovascular magnetic resonance: An emerging clinical biomarker 139
Thrombin induces protease-activated receptor 1 signaling and activation of human atrial fibroblasts and dabigatran prevents these effects 139
Prevalent cardiac, renal and cardiorenal damage in patients with advanced abdominal aortic aneurysms 137
Data regarding the effects of thrombin and dabigatran-inhibited thrombin on protease-activated receptor 1 and activation of human atrial fibroblasts 136
Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry 130
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness 127
Longitudinal trajectories of arterial stiffness and the role of blood pressure: the Baltimore Longitudinal Study of Aging. 124
Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy 124
Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients 124
The relationship between visceral adiposity and left ventricular diastolic function: results from the Baltimore Longitudinal Study of Aging. 124
Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia 123
Arterial stiffness and vitamin D levels: the Baltimore longitudinal study of aging. 122
The association between leptin and depressive symptoms is modulated by abdominal adiposity. 121
Prevalence and Prognostic Impact of Chronic Obstructive Pulmonary Disease in Patients with Chronic Heart Failure: Data from the GISSI-HF Trial 118
Clinical characteristics and prognostic impact of atrial fibrillation in patients with chronic heart failure 118
Methods, accuracy and clinical implications of atrial fibrillation detection by cardiac implantable electronic devices 117
Cancer diagnosis in patients with heart failure: Epidemiology, clinical implications and gaps in knowledge 117
[Cardiac cell therapy: the puzzle is waiting to be solved] 113
Linking Heart Failure to Cancer 113
Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure 112
What can we learn from pulmonary function testing in heart failure? 110
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 110
Early contribution of arterial wave reflection to left ventricular relaxation abnormalities in a community-dwelling population of normotensive and untreated hypertensive men and women. 108
Comparison of Outcomes in Patients With Nonobstructive, Labile-Obstructive, and Chronically Obstructive Hypertrophic Cardiomyopathy 108
Frequency, predictors and prognostic impact of implantable cardioverter defibrillator shocks in a primary prevention population with heart failure and reduced ejection fraction 107
Recurrent and residual shunts after patent foramen ovale closure: Results from a long-term transcranial doppler study 106
Role of bone mineral density in the inverse relationship between body size and aortic calcification: Results from the Baltimore Longitudinal Study of Aging. 105
Contribution of central adiposity to left ventricular diastolic function (from the Baltimore Longitudinal Study of Aging). 102
Impact of peak provoked left ventricular outflow tract gradients on clinical outcomes in hypertrophic cardiomyopathy 100
Time for an "Atrial-Watchful" Approach for Heart Failure Patients With a Cardiac Implantable Electronic Device 100
P38 MAPK and JNK antagonistically control senescence and cytoplasmic p16ink4a expression in doxorubicin-treated endothelial progenitor cells 100
Comparison of clinical presentation, left ventricular morphology, hemodynamics, and exercise tolerance in obese versus nonobese patients with hypertrophic cardiomyopathy. 98
ECHOCARDIOGRAPHIC AND CLINICAL CORRELATES OF SPECIFIC EARLY REPOLARIZATION SUBTYPES ON ELECTROCARDIOGRAM 98
Real-world versus trial patients with transthyretin amyloid cardiomyopathy 98
Impact of Central Obesity on the Estimation of Carotid-Femoral Pulse Wave Velocity. 97
Characteristics of current heart failure patients admitted to internal medicine vs. cardiology hospital units: the VASCO study 97
Relationship between vitamin D status and left ventricular geometry in a healthy population: results from the Baltimore Longitudinal Study of Aging 97
Prevalence, clinical correlates, and functional impact of subaortic ventricular septal bulge (from the Baltimore Longitudinal Study of Aging). 96
Amyloid Cardiomyopathy in the Rare Transthyretin Tyr78Phe Mutation 95
Diagnostic value of ischemia severity at myocardial perfusion imaging in elderly persons with suspected coronary disease 94
GENDER DIFFERENCES IN EARLY MANIFESTATIONS OF ARTERIAL STIFFNESS: RESULTS FROM THE SARDINIA PROJECT 92
Modes of death and prognostic outliers in chronic heart failure 92
Lower mitochondrial energy production of the thigh muscles in patients with low-normal ankle-brachial index 91
Long-Term Left Ventricular Remodeling of Patients With Hypertrophic Cardiomyopathy 91
Indoxyl sulfate: A candidate target for the prevention and treatment of cardiovascular disease in chronic kidney disease 90
Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease 89
Relationship between inter-arm difference in systolic blood pressure and arterial stiffness in community-dwelling older adults. 88
Sometimes they come back: recurrent noncardiac right-to-left shunt after percutaneous patent foramen ovale closure. 87
The Relationship Between Brain–Heart Autonomic Signaling and Aging: A Gender-Specific Longitudinal Perspective from the Baltimore Longitudinal Study on Aging 85
Longitudinal Association between Serum Uric Acid and Arterial Stiffness: Results from the Baltimore Longitudinal Study of Aging 85
Doxorubicin impairs the insulin-like growth factor-1 axis in H9c2 cells 82
Prevalence and Undertreatment of Prothrombotic Risk in Advanced Forms of Liver Disease 82
Human amniotic fluid stem cell secretome protects cardiomyocytes against doxorubicin toxicity 79
C–REACTIVE PROTEIN AS A PREDICTOR OF INTIMAL MEDIA THICKNESS IN A HEALTHY COMMUNITY DWELLING POPULATION OF A BROAD AGE RANGE 78
Brugada syndrome and syncope: a practical approach for diagnosis and treatment 75
Pulse wave velocity testing in the Baltimore longitudinal study of aging. 74
Letter regarding the article 'Heart failure with preserved ejection fraction: from mechanisms to therapies' by Lam and colleagues 72
Cancer Mortality in Trials of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis 66
Pulmonary and cardiac drugs: clinically relevant interactions 65
From arterial stiffness to heart failure: Still a long way to go 64
Metabolic and densitometric correlation between atherosclerotic plaque and trabecular bone: an 18F-Natrium-Fluoride PET/CT study 64
[Italian clinical trials on cardiac cell therapy: where we are and where are we going?] 58
Cancer in chronic heart failure patients in the GISSI-HF trial 58
Multiparametric vs. Inferior Vena Cava-Based Estimation of Right Atrial Pressure 56
Reply: The Barcelona Bio-HF Calculator: A Contemporary Web-Based Heart Failure Risk Score 55
[Clinical studies of cardiac cell therapy in Italy] 55
Very Short vs. Long Dual Antiplatelet Therapy after Second Generation Drug-eluting Stents in 35,785 Patients undergoing Percutaneous Coronary Interventions: a Meta-analysis of Randomised Controlled Trials 50
Duration of dual antiplatelet therapy and subsequent monotherapy type in patients undergoing drug eluting stent implantation: a network Meta-analysis 48
Effect of statin treatment on arterial stiffness in individuals with newly-diagnosed Heterozygous Familial Hypercholesterolemia. 47
Telehealth monitoring for hypertrophic cardiomyopathy and amyloid cardiomyopathy patients: Lessons from the coronavirus disease 2019 lockdown in Italy 46
Mechanical circulatory support in patients with cardiogenic shock not secondary to cardiotomy: a network meta-analysis 45
Testing longitudinal data for prognostication in ambulatory heart failure patients with reduced ejection fraction. A proof of principle from the GISSI-HF database 44
Bmi and acute kidney injury post transcatheter aortic valve replacement: Unveiling the obesity paradox 43
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 39
Prevalence of transthyretin amyloid cardiomyopathy in male patients who underwent bilateral carpal tunnel surgery: The ACTUAL study 39
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 38
The impossible quest to make cardiac amyloidosis diagnosis easy 38
Efficacy of new medical therapies in patients with heart failure, reduced ejection fraction and chronic kidney disease already receiving neurohormonal inhibitors: a network meta-analysis 35
Tailoring risk prediction at the patient level: future perspectives in cardiovascular medicine 35
Supremacy of echocardiography in the diagnostic workup of systemic AL amyloidosis 34
Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis 34
Chronic obstructive pulmonary disease and comorbidities in heart failure: the next frontier of sodium–glucose co-transporter 2 inhibitors? 32
Management of nonischemic-dilated cardiomyopathies in clinical practice: a position paper of the working group on myocardial and pericardial diseases of Italian Society of Cardiology 31
Acknowledging the complex puzzle that links heart failure hospitalizations to outcomes. Letter regarding the article ‘Readmission and death in patients admitted with new-onset versus worsening of chronic heart failure: insights from a nationwide cohort’ 30
Frequency, characteristics and prognostic impact of hospital readmissions in elderly patients with heart failure: A population study from 2013 to 2017 in Liguria, Northern Italy 29
Impact of bioprosthetic valve type on peri-procedural myocardial injury and mortality after transcatheter aortic valve replacement 29
Diagnostic yield and predictive value on left ventricular remodelling of genetic testing in dilated cardiomyopathy 26
Yield of bone scintigraphy screening for transthyretin-related cardiac amyloidosis in different conditions: Methodological issues and clinical implications 25
Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis 23
Cardiac amyloidosis: a changing epidemiology with open challenges 22
Corrigendum to "Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis" [International Journal of Cardiology Volume 357, 15 June 2022, Pages 88-94] 22
Totale 8.750
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.858
article - articoli 33.204
book - libri 0
conference - conferenze 1.654
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.716
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.058 0 0 0 0 240 277 354 234 272 391 220 70
2020/20211.174 56 124 109 176 81 51 80 113 75 133 83 93
2021/20221.148 31 28 73 106 46 108 63 276 83 117 35 182
2022/20231.246 117 119 24 122 193 186 17 88 201 10 152 17
2023/2024780 34 92 17 108 74 108 49 59 51 29 46 113
2024/2025674 89 174 59 168 184 0 0 0 0 0 0 0
Totale 9.176